Understanding the structure of the HIV-2 virus capsid
Official title: Structural characterization of the HIV-2 capsid lattice
Funded at University of Minnesota · NIH-10947460 · Data updated 2026-11-12
This study is looking at the structure of the HIV-2 virus to find new ways to treat it, and it could help people living with HIV by discovering better therapies in the future.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project start | September 27, 2024 |
| Project end | September 26, 2026 |
| Funding year | 2024 |
| Award (this year) | $45,915 |
| NIH project number | 1F31AI184673-01 |
| Project ID | NIH-10947460 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals living with HIV-2 or those at risk of HIV-2 infection.
✕Less likely to help
Patients with HIV-1 may not receive direct benefits from this research focused specifically on HIV-2.
What this research studies
This research investigates the structural characteristics of the HIV-2 capsid, which is crucial for understanding how the virus assembles and replicates. By examining the differences in the capsid protein structure and interactions, the study aims to identify potential targets for new antiviral therapies. The research involves detailed comparisons between HIV-1 and HIV-2 to uncover unique features that could lead to breakthroughs in treatment. Patients may benefit from insights gained that could inform future therapies aimed at curing HIV.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antiviral therapies that are more effective against HIV-2.
How similar studies have gone: Previous research has shown promise in understanding HIV-1 capsid structure, suggesting that similar approaches for HIV-2 could yield valuable insights.
Where this research is happening
-
University of Minnesota
Minneapolis, United States Active
Researchers
- Principal investigator: Arndt, William — University of Minnesota
- Study coordinator: Arndt, William
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.